Toyonaga, Takahiko
Kobayashi, Taku http://orcid.org/0000-0002-2073-4234
Kuronuma, Satoshi
Ueno, Aito
Kiyohara, Hiroki
Okabayashi, Shinji
Takeuchi, Osamu
Redfern, Christopher P. F.
Terai, Hideki
Ozaki, Ryo
Sagami, Shintaro
Nakano, Masaru
Coulthard, Sally A.
Tanaka, Yoichi
Hibi, Toshifumi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP19K17443)
JGW Patterson Foundation
Medical Research Council (mc-pc-14101v.2)
Japan Foundation for Applied Enzymology
Ministry of Health, Labour and Welfare
Newcastle Healthcare Charity
Article History
Received: 25 May 2021
Accepted: 21 August 2021
First Online: 4 September 2021
Declarations
:
: T. Toyonaga receives research grants from Pfizer Inc. T. Kobayashi receives lecture fees from Abbvie Inc, Kyorin Pharmaceutical, Mitsubishi Tanabe, EA Pharma, Medtronic Co., Ltd, Janssen, Mochida Pharmaceutical, Takeda Pharmaceutical, Gilead Sciences, Nippon Kayaku, JIMRO, ZERIA Pharmaceutical, Astellas, Asahi Kasei Medical, Thermo Fisher Scientific, and Pfizer, advisory/consulting board fees from Abbvie Inc, Alfresa Pharma, Celltrion, Pfizer, Eli Lilly, Ferring Pharmaceuticals, Covidien, Janssen, Mochida Pharmaceutical, Takeda Pharmaceutical, Gilead Sciences, Nippon Kayaku, ZERIA Pharmaceutical, Thermo Fisher Scientific, and EA Pharma, and grants from EA Pharma, Thermo Fisher Scientific, Alfresa Pharma, and Nippon Kayaku. T. Hibi receives lecture fees from Mitsubishi-Tanabe Pharma, Kyorin Pharmaceutical, Abbvie GK, Janssen, JIMRO Co., Ltd, EA Pharma, Mochida Pharmaceutical, Takeda Pharmaceutical, Gilead Sciences, Celltrion, Nippon Kayaku, Kissei Pharmaceutical, Miyarisan Pharmaceutical, Zeria Pharmaceutical, and Ferring Pharmaceutical, advisory/consulting board fees from Abbvie GK,Takeda Pharmaceutical, Mitsubishi-Tanabe Pharma, JIMRO Co., Ltd, EA Pharma, Eli Lilly, Pfizer Japan Inc, Nichi-Iko Pharmaceutical, and Nippon Kayaku, and research grants from EA Pharma, Abbvie GK, JIMRO Co., Ltd, Zeria Pharmaceutical, Otsuka Pharmaceutical Co., Ltd. M. Nakano receives lecture/consultant fees from Covidien, Mochida Pharmaceutical, Takeda Pharmaceutical, Zeria Pharmaceutical, Kyorin Pharmaceutical and Nippon Kayaku, and research fundings from Mitsubishi Tanabe Pharma and Japanese foundation for research and promotion of endoscopy. S. Sagami has served as a speaker for AbbVie, Takeda Pharmaceutical, Zeria Pharmaceutical, served as a consultant for Nippon Kayaku, and an endowed chair from AbbVie, EA Pharma, JIMRO, Kyorin Pharmaceutical, Mochida Pharmaceutical, and Zeria Pharmaceutical, and has received research funding from Japan Foundation for Applied Enzymology.